These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Successful outpatient graded administration of trimethoprim-sulfamethoxazole in patients without HIV and with a history of sulfonamide adverse drug reaction. Pyle RC; Butterfield JH; Volcheck GW; Podjasek JC; Rank MA; Li JT; Harish A; Poe KL; Park MA J Allergy Clin Immunol Pract; 2014; 2(1):52-8. PubMed ID: 24565769 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection. Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715 [TBL] [Abstract][Full Text] [Related]
5. Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Shapiro LE; Knowles SR; Weber E; Neuman MG; Shear NH Drug Saf; 2003; 26(3):187-95. PubMed ID: 12580647 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group. Walmsley SL; Khorasheh S; Singer J; Djurdjev O J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):498-505. PubMed ID: 9859964 [TBL] [Abstract][Full Text] [Related]
7. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting. Nguyen AT; Gentry CA; Furrh RZ Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. Abouraya M; Sacco JC; Kahl BS; Trepanier LA Br J Clin Pharmacol; 2011 Apr; 71(4):566-74. PubMed ID: 21204907 [TBL] [Abstract][Full Text] [Related]
9. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Neuman MG; Malkiewicz IM; Phillips EJ; Rachlis AR; Ong D; Yeung E; Shear NH Ther Drug Monit; 2002 Dec; 24(6):728-36. PubMed ID: 12451289 [TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient. Bell TL; Foster JN; Townsend ML Pharmacotherapy; 2010 May; 30(5):539. PubMed ID: 20412003 [TBL] [Abstract][Full Text] [Related]
12. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection]. Piketty C; Gilqouin J; Kazatchkine M Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734 [TBL] [Abstract][Full Text] [Related]
13. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients. Urbancic KF; Pisasale D; Wight J; Trubiano JA Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892 [TBL] [Abstract][Full Text] [Related]
14. Sulfonamide allergies and outcomes related to use of potentially cross-reactive drugs in hospitalized patients. Hemstreet BA; Page RL Pharmacotherapy; 2006 Apr; 26(4):551-7. PubMed ID: 16553515 [TBL] [Abstract][Full Text] [Related]
15. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. Para MF; Finkelstein D; Becker S; Dohn M; Walawander A; Black JR J Acquir Immune Defic Syndr; 2000 Aug; 24(4):337-43. PubMed ID: 11015150 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity between darunavir and trimethoprim-sulfamethoxazole in HIV-infected patients. Buijs BS; van den Berk GE; Boateng CP; Hoepelman AI; van Maarseveen EM; Arends JE AIDS; 2015 Apr; 29(7):785-91. PubMed ID: 25985401 [TBL] [Abstract][Full Text] [Related]
17. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions. Shafer RW; Seitzman PA; Tapper ML J Acquir Immune Defic Syndr (1988); 1989; 2(4):389-93. PubMed ID: 2526871 [TBL] [Abstract][Full Text] [Related]
18. Successful extracorporeal liver dialysis for the treatment of trimethoprim-sulfamethoxazole-induced fulminant hepatic failure. Ng CT; Tan CK; Oh CC; Chang JP Singapore Med J; 2013 May; 54(5):e113-6. PubMed ID: 23716163 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients. Carr A; Penny R; Cooper DA AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919 [TBL] [Abstract][Full Text] [Related]
20. Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients. Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA AIDS; 1994 Mar; 8(3):333-7. PubMed ID: 8031511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]